Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI Worldwide, MilanCPhI Worldwide, Milan
Not Confirmed
Not Confirmed
08-10 October, 2024
Discovery on TargetDiscovery on Target
Not Confirmed
Not Confirmed
30 September-03 October, 2024
Not Confirmed
Not Confirmed
30 September-02 October, 2024
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI Worldwide, MilanCPhI Worldwide, Milan
Industry Trade Show
Not Confirmed
08-10 October, 2024
Discovery on TargetDiscovery on Target
Industry Trade Show
Not Confirmed
30 September-03 October, 2024
Industry Trade Show
Not Confirmed
30 September-02 October, 2024
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/ice-is-pioneering-sustainability-innovation-in-bile-acid-research-for-neurodegenerative-diseases
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/2024-us-elections-harris-trump-differ-on-abortion-rights-aca-public-health-spends-agree-on-need-to-cut-drug-prices
18 Sep 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/09/18/2948200/34858/en/Vaccinex-Announces-Exercise-of-Warrants-for-6-2-Million-in-Gross-Proceeds.html
14 Aug 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/08/14/2930062/34858/en/Vaccinex-Provides-Update-on-New-Findings-for-SIGNAL-AD-Phase-1b-2-Trial-of-Pepinemab-in-Alzheimer-s-Disease-and-Plans-to-Pursue-a-Development-Partnership.html
31 Jul 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/07/31/2921918/34858/en/Vaccinex-Reports-Positive-Data-for-SIGNAL-AD-Phase-1b-2-trial-of-Pepinemab-in-Alzheimer-s-Disease.html
17 Jul 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/07/17/2914515/34858/en/Vaccinex-to-report-topline-data-for-SIGNAL-AD-Phase-1b-2-trial-of-Pepinemab-in-Alzheimer-s-Disease-at-the-Alzheimer-s-Association-International-Conference-Philadelphia-July-31-2024.html
06 Jun 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/06/06/2894654/34858/en/Vaccinex-Reports-Completion-of-Last-Patient-Visit-in-Randomized-SIGNAL-AD-Phase-1b-2-Study-of-Pepinemab-Treatment-for-Alzheimer-s-Disease.html
15 May 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/05/15/2883005/34858/en/Vaccinex-Reports-First-Quarter-2024-Financial-Results-and-Provides-Corporate-Update.html
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?